Suppr超能文献

布尼洛尔的代谢及其被西咪替丁抑制的情况。

Bunitrolol metabolism and its inhibition by cimetidine.

作者信息

Ishida R, Fujita S, Suzuki T

机构信息

Department of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Chiba University, Japan.

出版信息

J Pharm Pharmacol. 1988 Jan;40(1):64-5. doi: 10.1111/j.2042-7158.1988.tb05155.x.

Abstract

A simple fluorometric assay method as well as a sensitive HPLC method for determination of bunitrolol, a beta-adrenoreceptor blocking drug, and its 4-hydroxylated metabolite is described. More than 90% of bunitrolol metabolized was accounted for by the formation of 4-hydroxybunitrolol in rat hepatic microsomes. Bunitrolol 4-hydroxylation required NADPH, and was inhibited by CO, proadifen and metyrapone, indicating that this reaction is mediated by cytochrome P450. This reaction was also inhibited by cimetidine competitively, and the inhibition constant, Ki, was 40 +/- 11.5 microM (mean +/- s.e. n = 3).

摘要

描述了一种简单的荧光测定法以及一种灵敏的高效液相色谱法,用于测定β-肾上腺素受体阻断药布尼洛尔及其4-羟基化代谢物。在大鼠肝微粒体中,超过90%代谢的布尼洛尔是由4-羟基布尼洛尔的形成所致。布尼洛尔的4-羟基化需要NADPH,并受到一氧化碳、丙磺舒和甲吡酮的抑制,表明该反应由细胞色素P450介导。该反应也受到西咪替丁的竞争性抑制,抑制常数Ki为40±11.5微摩尔(平均值±标准误,n = 3)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验